The GLP Inspection Odyssey: A Regulatory Professional's Journey Through PMDA Compliance for Non-Clinical Safety Studies in Japan

Chapter 1: The First Challenge

Meet Aiko, a dedicated regulatory affairs manager at a mid-sized Japanese pharmaceutical company. Her team had just submitted the marketing authorisation application for a promising new oncology drug. The non-clinical safety studies—conducted at a domestic test facility—were central to the dossier. One morning, Aiko received an official letter from the Pharmaceuticals and Medical Devices Agency (PMDA): a routine GLP inspection had been scheduled for her facility. She felt a mix of excitement and anxiety. “What exactly does PMDA look for?” she wondered. Her mentor, an experienced veteran named Hiroshi, smiled and said, “This is your chance to learn the heart of GLP compliance in Japan. Let me walk you through the journey we took last year.” https://www.pmda.go.jp/english/review-services/glp-gcp-gpsp/0002.html

Chapter 2: Understanding the Three Types of Inspections

Hiroshi began with the basics. “PMDA conducts three kinds of GLP inspections to ensure high-quality, reliable non-clinical safety data. First, there’s the routine inspection—periodic, voluntary for domestic facilities, covering both facility checks and study audits. If successful, you receive a GLP Certificate valid for three years. This is what your facility is facing now. Then there’s the product-based inspection, triggered by a marketing authorisation application when studies come from facilities without a valid PMDA certificate or from outside OECD MAD countries. Finally, special inspections occur whenever PMDA needs them—perhaps after a whistle-blower report or a review office request.” Aiko noted every word. Hiroshi added, “Importantly, PMDA does not accept routine GLP inspection applications from test facilities outside Japan.” https://www.pmda.go.jp/english/review-services/glp-gcp-gpsp/0002.html

Chapter 3: The Power of Mutual Acceptance of Data (MAD)

As they reviewed the facility’s study plans, Hiroshi explained the international angle. “Japan is an OECD member since 1964, so we benefit from the Mutual Acceptance of Data (MAD) system. Data from GLP-compliant facilities in MAD-adherent countries are accepted without re-inspection. But for countries outside the MAD framework—or provisional adherents—PMDA may refuse the data or conduct a product-based inspection. In our last project, we used a U.S. lab with an OECD GLP certificate; that saved us months.” Aiko realised why her overseas colleagues always emphasised MAD compliance. https://www.pmda.go.jp/english/review-services/glp-gcp-gpsp/0002.html

Chapter 4: Preparing for the Routine Inspection Day

The inspection day arrived. PMDA inspectors reviewed organisation charts, SOPs, training records, animal housing, environmental controls, and computerised systems. They audited two key studies line by line. Aiko’s team had prepared the required documents: facility layout, QA unit structure, calibration records, and waste disposal procedures. At the closing meeting, the lead inspector praised the team’s meticulous archiving and clear delegation of study director responsibilities. “Your facility meets GLP standards,” he announced. Three weeks later, the GLP Certificate arrived—valid for three years. Aiko felt proud; the data would now be automatically accepted in the review. https://www.pmda.go.jp/english/review-services/glp-gcp-gpsp/0002.html

Chapter 5: The Lesson That Changed Everything

Hiroshi later reflected, “The real victory wasn’t just the certificate—it was understanding that GLP is about generating reliable data from the start. For overseas studies without MAD protection, we now plan product-based inspections early. And remember: even with a certificate, if issues arise during review, a special inspection can still happen.” Aiko smiled. “I used to see compliance as paperwork. Now I see it as protecting patients and speeding approvals.” Her team’s drug was approved six months later, thanks in part to the flawless GLP foundation. https://www.pmda.go.jp/english/review-services/glp-gcp-gpsp/0002.html

Chapter 6: Practical Takeaways for Every Regulatory Professional

From Aiko’s story, remember these PMDA truths: routine inspections build long-term trust for domestic facilities; product-based inspections verify studies when certificates are missing; MAD opens doors to global data; and meticulous preparation—SOPs, training, archiving—turns inspections into opportunities. Always consult the latest Ministerial Ordinances and PMDA guidance. The journey may feel daunting, but mastering GLP compliance unlocks faster, safer pathways to market. https://www.pmda.go.jp/english/review-services/glp-gcp-gpsp/0002.html